Patent holdings for IPC class A61K 31/427

Total number of patents in this class: 3969

10-year publication summary

238
203
233
235
210
248
215
191
236
206
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Novartis AG
10656
60
Merck Sharp & Dohme LLC
3734
59
F. Hoffmann-La Roche AG
7932
48
Takeda Pharmaceutical Company Limited
2717
44
The Regents of the University of California
20230
40
Dana-Farber Cancer Institute, Inc.
2615
37
Gilead Sciences, Inc.
2070
36
The United States of America, as represented by the Secretary, Department of Health and Human Services
2895
36
Bristol-myers Squibb Company
4848
35
Daiichi Sankyo Company, Limited
1878
35
Boehringer Ingelheim International GmbH
4648
34
Janssen Pharmaceutica N.V.
3349
31
Abbvie Inc.
1812
28
Shionogi & Co., Ltd.
839
27
Hoffmann-La Roche Inc.
3516
25
Genentech, Inc.
4008
25
Pfizer Inc.
3397
24
Astellas Pharma Inc.
1056
21
Centre National de La Recherche Scientifique
10635
20
The Trustees of the University of Pennsylvania
4376
20
Other owners 3284